ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

Á¥ÊôµÚÒ»Ò½Ôº¿Â×ð¸»Ö÷ÈÎҽʦÍŶÓÔÚClinical Cancer ResearchÆÚ¿¯½ÒÏþÇý¶¯»ùÒòÒõÐÔ·ÎÏÙ°©Ñо¿Ð§¹û

ÔĶÁÁ¿£º£º

11ÔÂ3ÈÕ£¬£¬£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÒ»Ò½Ôº²¡Àí¿Æ¿Â×ð¸»Ö÷ÈÎҽʦ·Î°©Ñо¿ÍŶÓÔÚClinical Cancer Research (IF 2017=10.19£©ÆÚ¿¯ÉϽÒÏþÁËÑо¿ÐÔÂÛÎÄDevelopment and validation of a novel signature to predict overall survival in ¡°driver-gene-negative¡± lung adenocarcinoma (LUAD): results of a multicenter study(online first),Á¥ÊôµÚһҽԺΪΨһͨѶµ¥Î»£¬£¬£¬µÚÒ»×÷ÕßΪºôÎüÓëÎ£ÖØÖ¢Ò½Ñ§¿ÆÌƿɾ©¸±½ÌÊÚ¡¢Ñо¿ÖúÀí´Þӽ÷¡£¡£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

CSDW½¨Ä£Àú³Ì

¸ÃÑо¿Ö¼ÔÚ̽Ë÷·¢Óý×éÐźÅͨ·ÔÚÇý¶¯»ùÒòÒõÐÔ·ÎÏÙ°©ÖеÄ×÷Ó㬣¬£¬²¢Ì½Ñ°ÓëÇý¶¯»ùÒòÒõÐÔ·ÎÏÙ°©»¼ÕßÔ¤ºóÏÔÖøÏà¹ØµÄ·Ö×Ó£¬£¬£¬ÒÔÆÚΪ´ËÀàÔ¤ºó²îµÄ²¡ÈËÌṩеÄÖÎÁưеã¡£¡£ÊµÑé·ÖΪ3´ó²¿·Ö£º£º·¢Ã÷½×¶Î¡¢ÊµÑé½×¶ÎÒÔ¼°ÑéÖ¤½×¶Î¡£¡£ÔÚ·¢Ã÷½×¶Î£¬£¬£¬¿ÎÌâ×éʹÓÃÈ«»ùÒò×éоƬ¶Ô52¶ÔÇý¶¯»ùÒòÒõÐÔ·ÎÏÙ°©Ö×Áö×éÖ¯ºÍÏàÁÚÕý³£×éÖ¯¾ÙÐкòÑ¡»ùÒòµÄɸѡ£¬£¬£¬Í¨¹ýKEGGÐźÅͨ·¸»¼¯ÆÊÎö·¢Ã÷Wnt/¦Â-cateninÐźÅͨ·ÔÚÇý¶¯»ùÒòÒõÐÔ·ÎÏÙ°©Öи߶ȼ¤»î£¬£¬£¬²¢»ñµÃ41¸öWnt/¦Â-cateninÐźÅͨ·Ïà¹ØµÄ²î±ð±í´ï»ùÒò¡£¡£ÔÚʵÑé½×¶Î£¬£¬£¬¿ÎÌâ×éÔËÓÃ×é֯оƬÊÖÒÕ(TMAs)ºÍLASSO Cox»Ø¹éÆÊÎö½øÒ»²½¶Ô41¸öºòÑ¡»ùÒò¾ÙÐÐɸѡ£¬£¬£¬×îÖÕ¹¹½¨ÁËÒ»¸öÓÉCTNNB1¡¢SOX9¡¢DVL3ºÍWnt2b×é³ÉµÄÔ¤ºóÏà¹Øclassifier£¨CSDW£©¡£¡£ÒÀ¾ÝCSDW classifier,Çý¶¯»ùÒòÒõÐÔ·ÎÏÙ°©»¼Õ߿ɱ»·ÖΪ¸ß·çÏÕ×éºÍµÍ·çÏÕ×飬£¬£¬²¢ÇҸ߷çÏÕ»¼ÕßµÄ×ÜÉúÑÄÂÊÏÔÖø²îÓڵͷçÏÕ»¼Õߣ¨[HR]10.42,6.46-16.79;p<0 .001£©¡£¡£ÔÚÑéÖ¤½×¶Î£¬£¬£¬¿ÎÌâ×éÍøÂçÁËÄÚ²¿ÑéÖ¤×éÑù±¾ºÍÁ½¸ö×ÔÁ¦µÄÍⲿÑéÖ¤×éÑù±¾¡£¡£¾­ÓÉÑéÖ¤ÆÊÎö£¬£¬£¬csdw classifier±»Ö¤Êµ¿É×÷ΪԤ²âÇý¶¯»ùÒòÒõÐÔ·ÎÏÙ°©»¼ÕßÔ¤ºóµÄ¿É¿¿¹¤¾ß£¬£¬£¬Í¬Ê±ÎªÇý¶¯»ùÒòÒõÐÔ·ÎÏÙ°©µÄÖÎÁÆÌṩеİеã¡£¡£

¸ÃÏîÑо¿ÊÂÇé»ñµÃÁ¥ÊôµÚÒ»Ò½Ôº¡°Èý¸öÈý¡±¹¤³ÌÏîÄ¿¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿¡¢¹ã¶«Ê¡×ÔÈ»¿ÆÑ§»ù½ðµÄ×ÊÖú¡£¡£

ÂÛÎÄÁ´½Ó£º£ºhttp://clincancerres.aacrjournals.org/content/early/2018/11/02/1078-0432.CCR-18-2545.long

¡¾ÍøÕ¾µØÍ¼¡¿